Why the study?
Does a three-stage screening program identify SMA carriers and affected fetuses in pregnant women?
Population
107,611 pregnant women from 25 counties in Taiwan
Design
Cohort
Authors
Loading...
Supports feasibility of SMA carrier screening in pregnancy; leaves open whether routine adoption improves outcomes.
Does a three-stage screening program identify SMA carriers and affected fetuses in pregnant women?
A large-scale three-stage screening program in pregnant women is feasible and effective for identifying SMA carriers and diagnosing affected fetuses.
Su et al. (2011) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: